The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study

OBJECTIVE: To evaluate the non-inferiority of pramipexole extended-release (ER) versus immediate-release (IR) in Chinese patients with Parkinson’s disease (PD) in a double-blind, randomized, parallel-group study. METHODS: Subjects were Chinese patients with idiopathic PD with diagnosis ≥ 2 years pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Sun, Shenggang, Zhu, Suiqiang, Liu, Chunfeng, Liu, Yiming, Di, Qing, Shang, Huifang, Ren, Yan, Lu, Changhong, Gordon, Mark Forrest, Juhel, Nolwenn, Chen, Shengdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128609/
https://www.ncbi.nlm.nih.gov/pubmed/25114789
http://dx.doi.org/10.1186/2047-9158-3-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128609/
https://www.ncbi.nlm.nih.gov/pubmed/25114789
http://dx.doi.org/10.1186/2047-9158-3-11

Ejemplares similares